The Angiogenic Factor Secretoneurin Induces Coronary Angiogenesis in a Model of Myocardial Infarction by Stimulation of Vascular Endothelial Growth Factor Signaling in Endothelial Cells
Author(s) -
Karin Albrecht-Schgoer,
Wilfried Schgoer,
Johannes Holfeld,
Markus Theurl,
Dominik Wiedemann,
Christina Steger,
Rajesh Gupta,
Severin Semsroth,
Reiner FischerColbrie,
Arno Beer,
Ursula Stanzl,
E. Huber,
Sol Misener,
Daniel Dejaco,
Raj Kishore,
Otmar Pachinger,
Michael Grimm,
Nikolaos Bonaros,
Rudolf Kirchmair
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.076950
Subject(s) - medicine , angiogenesis , vascular endothelial growth factor , myocardial infarction , stimulation , vascular endothelial growth factor a , vascular endothelial growth factor b , endothelial stem cell , cardiology , cancer research , vegf receptors , biology , in vitro , biochemistry
Secretoneurin is a neuropeptide located in nerve fibers along blood vessels, is upregulated by hypoxia, and induces angiogenesis. We tested the hypothesis that secretoneurin gene therapy exerts beneficial effects in a rat model of myocardial infarction and evaluated the mechanism of action on coronary endothelial cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom